Structure-Based Drug Design | List of High Impact Articles | PPts | Journals | Videos

Journal of Cellular and Molecular Pharmacology
Open Access

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)

Structure-Based Drug Design

Structure-based drug design is the design and optimization of a chemical structure with the goal of identifying a compound suitable for clinical testing — a drug candidate. It is based on knowledge of the drug’s three-dimensional structure and how its shape and charge cause it to interact with its biological target, ultimately eliciting a medical effect. The drug is most commonly an organic small molecule that activates or inhibits the function of a bio molecule such as a protein, which in turn results in a therapeutic benefit to the patient. Drug design or rational drug design or simply rational design, is the inventive process of finding new medications based on the knowledge of a biological target. Drug design involves the design of small molecules that are complementary in shape and charge to the bio molecular target with which they interact and therefore will bind to it.

Related Journals: Chemical Biology and Drug Design, Current Computer-Aided Drug Design, Drug Design, Development and Therapy, International Journal of Computational Biology and Drug Design, Letters in Drug Design and Discovery, Current Drug Delivery, Current Drug Discovery Technologies, Current Drug Metabolism 9. Current Drug Safety

Structure-Based Drug Design

Expert PPTs

Speaker PPTs

Conference Proceedings